Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

CompletedOBSERVATIONAL

Enrollment

1,099

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2009

Conditions

Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004%

1 drop in eye(s) every evening

Trial Locations (1)

Murfreesboro